Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. 2006N-0472]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
 DATES: Fax written comments on the collection of information by April 16, 2007.
 ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-6974.
 FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of the Chief Information Officer (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301- 827-1472.


SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed—21 CFR 589.2000(e)(1)(iv) (OMB Control Number 0910-0339)—Extension This information collection was established because epidemiological evidence gathered in the United Kingdom suggested that bovine spongiform encephalopathy (BSE), a progressively degenerative central nervous system disease, is spread to ruminant animals by feeding protein derived from ruminants infected with BSE. That regulation places general requirements on persons that manufacture, blend, process, and distribute products that contain or may contain protein derived from mammalian tissue, and feeds made from such products. In the 
                    **Federal Register**
                     of December 4, 2006 (71 FR 70409), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received. The respondents for this collection of information are manufacturers and or distributors of products that contain or may contain protein derived from mammalian tissues and feeds made from such products. **Table 1.—Estimated Annual Recordkeeping Burden**1
21 CFR Section
No. of
                             Recordkeepers
Annual Frequency
                             per Recordkeeping
Total Annual
                             Records
Hours per
                             Record
Total Hours589.2000(e)(1)(iv)
400
1
400
14
5,6001
                        There are no capital costs or operating and maintenance costs associated with this collection of information.
 Dated: March 7, 2007. Jeffrey Shuren, Assistant Commissioner for Policy.


[FR Doc. E7-4685 Filed 3-14-07; 8:45 am] BILLING CODE 4160-01-S